Mitomycin/hyaluronan complex
Alternative Names: Hyaluronic acid/mitomycin complex; Mitomycin C + HA; Mitomycin-hyaluronic acid complex; Mitomycin/hyaluronic acid complexLatest Information Update: 15 Aug 2002
At a glance
- Originator Nonindustrial source; Shiseido
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer metastases
Most Recent Events
- 23 Jul 1997 Mitomycin/hyaluronic acid complex is now called mitomycin/hyaluronan complex
- 26 Sep 1996 Preclinical development for Cancer metastases in Japan (Unknown route)